Revvity debuts AssayMate

Revvity has rolled out AssayMate, a benchtop machine that automates pipetting for lab assays and targets smaller labs that still do much of that work by hand. (revvity.com) The company debuted AssayMate at SLAS 2026 in Boston, where Revvity said the workstation was one of several new discovery platforms shown February 7-11. Revvity’s product page describes it as a compact system designed for bench use rather than a larger robotic setup. (financialcontent.com) (revvity.com) Liquid handling is the routine lab task of moving tiny volumes of liquid between tubes and plates, usually with handheld pipettes or larger robots. Revvity says AssayMate is meant to sit between those two extremes, with a fixed 8-channel head, a gripper, and support for volumes from 3 to 1,000 microliters without changing heads. (revvity.com) Revvity is pitching the system on price and simplicity as much as speed. Its brochure calls AssayMate a “budget-friendly” option for medium-throughput labs, and the company says it does not require extensive training. (revvity.com 1) (revvity.com 2) That matters in a market where full liquid-handling workstations can be too large or too expensive for smaller research groups, even when those groups run repetitive plate-based assays every day. Revvity says automation can cut hands-on time, reduce errors, and improve reproducibility, which is the lab term for getting the same result when a test is repeated. (revvity.com 1) (revvity.com 2) AssayMate also fits a broader push by instrument makers to sell more compact automation rather than only high-end integrated systems. Revvity says it has been supplying liquid-handling tools for more than 40 years and now markets products ranging from benchtop units to larger workflow platforms. (revvity.com 1) (revvity.com 2) The company has backed the launch with demos and training content, including a webinar that walks through the software and protocol-building process. Revvity’s SLAS 2026 event page also listed AssayMate among the products it was highlighting to attendees. (revvity.com) (revvity.com) If smaller labs adopt machines like this for routine assays, some day-to-day work now done with manual pipettes could shift to automated runs on the bench instead. Revvity’s pitch is that labs do not need a full robotics buildout to make that move. (revvity.com) (revvity.com)